Suzanne Morgan

Director, Market Access Strategy & Marketing, National Accounts & Patient Services Stealth BioTherapeutics

Dr. Suzanne Morgan is the Executive Director of Market Access at Stealth BioTherapeutics. With over 30 years in biotech leadership, she has built her career on the belief that patients deserve access to life-changing therapies without unnecessary barriers. Her leadership is grounded in compassion, steadiness, and the quiet strength that comes from faith. Dr. Morgan’s personal experiences, including overcoming personal valleys, have refined her leadership style, which is humble, grounded, and steady. She is passionate about how AI can help rare disease families and is committed to leading with strength and character. Dr. Morgan’s journey reflects her resilience and the character that carries her through everything in between.

Seminars

Thursday 16th July 2026
FDA Approval: Now What?
3:00 pm
  • Defining strategies for EAP patients that are now ready to be transferred to commercial products
Suzanne Morgan, Executive Director & Head, Market Access, Stealth Biotherapeutics